The Early Protective Effect of Hydroxychloroquine on the Risk of Cumulative Damage in Patients with Systemic Lupus Erythematosus
- 15 April 2013
- journal article
- research article
- Published by The Journal of Rheumatology in The Journal of Rheumatology
- Vol. 40 (6), 831-841
- https://doi.org/10.3899/jrheum.120572
Abstract
Objective. To assess whether hydroxychloroquine (HCQ) prevents early damage in patients with systemic lupus erythematosus (SLE). Methods. We updated an existing systematic review of literature on clinical effects of HCQ in patients with SLE. We conducted a nested case-control study embedded in an inception cohort of patients with SLE. Systemic Lupus International Collaborating Clinics Damage Index (SDI) at 3 years was considered as our primary outcome. Patients with SDI > 0 at 3 years were considered cases and patients with SDI = 0 were controls. Cases and controls were first compared by univariate analysis. Then conditional logistic regression models adjusting for potential confounders were done to study the effect of HCQ on damage accrual. Results. Included in the analysis were 481 patients who had 3 or more years of followup. Out of this cohort, we could match 151 cases with 151 controls. Univariate analysis identified age, the use of any immunosuppressive drugs, HCQ, and cumulative dose of steroids as significant covariates associated with damage accrual. In multivariate analysis, the use of HCQ remained significantly associated with less damage (OR 0.34, 95% CI 0.132–0.867), while age (OR 1.05, 95% CI 1.027–1.078) and a variable combining SLE activity and steroid dose (OR 1.73, 95% CI 1.306–2.295) were associated with damage at 3 years. Conclusion. We demonstrated that HCQ use was associated with less damage at 3 years after diagnosis of SLE when attention was given and adjustment done for disease activity and steroid dose, duration of disease, and calendar year of diagnosis.Keywords
This publication has 73 references indexed in Scilit:
- Hydroxychloroquine and Glycemia in Women with Rheumatoid Arthritis and Systemic Lupus ErythematosusThe Journal of Rheumatology, 2010
- Possible protective effect of hydroxychloroquine on delaying the occurrence of integument damage in lupus: LXXI, data from a multiethnic cohortArthritis Care & Research, 2010
- Variability over time and correlates of cholesterol and blood pressure in systemic lupus erythematosus: a longitudinal cohort studyArthritis Research & Therapy, 2010
- Protective effect of hydroxychloroquine on renal damage in patients with lupus nephritis: LXV, data from a multiethnic US cohortArthritis Care & Research, 2009
- Predictors of major infections in systemic lupus erythematosusArthritis Research & Therapy, 2009
- Clinical efficacy and side effects of antimalarials in systemic lupus erythematosus: a systematic reviewAnnals Of The Rheumatic Diseases, 2008
- Risk and protective factors for thrombosis in systemic lupus erythematosus: results from a large, multi-ethnic cohortAnnals Of The Rheumatic Diseases, 2008
- Effect of hydroxychloroquine on the survival of patients with systemic lupus erythematosus: data from LUMINA, a multiethnic US cohort (LUMINA L)Annals Of The Rheumatic Diseases, 2007
- Antimalarials may influence the risk of malignancy in systemic lupus erythematosusAnnals Of The Rheumatic Diseases, 2007
- High prevalence of the metabolic syndrome in patients with systemic lupus erythematosus: association with disease characteristics and cardiovascular risk factorsAnnals Of The Rheumatic Diseases, 2006